CDKN2B and central nervous system cancer: At k = 10, the genes screened in this study were CDK4, CDKN2B, TP53, NF1, FGFRCDKN2A, TP53, PRF1, RB1, and SIGLEC9, and the enriched pathways were Glioma and Cell Cycle.